09.11.2022 16:35 | SAR | Price Monitoring Extension | RNS |
09.11.2022 14:05 | SAR | Second Price Monitoring Extn | RNS |
09.11.2022 14:00 | SAR | Price Monitoring Extension | RNS |
09.11.2022 11:05 | SAR | Second Price Monitoring Extn | RNS |
09.11.2022 11:00 | SAR | Price Monitoring Extension | RNS |
09.11.2022 09:05 | SAR | Second Price Monitoring Extn | RNS |
09.11.2022 09:00 | SAR | Price Monitoring Extension | RNS |
08.11.2022 17:23 | SAR | Update on SDC-1801 CTA Application | RNS |
24.10.2022 10:28 | GSK, SAR | IN BRIEF: Sareum widens annual loss; considers future of SRA737 | Alliance |
24.10.2022 07:00 | SAR | Final Results for the Year Ended 30 June 2022 | RNS |
12.10.2022 10:47 | SAR, GSK | Sareum plunges as GSK subsidiary Sierra returns rights for SRA737 | Alliance |
12.10.2022 07:00 | SAR | Update on SRA737 | RNS |
30.09.2022 16:41 | SAR | Second Price Monitoring Extn | RNS |
30.09.2022 16:36 | SAR | Price Monitoring Extension | RNS |
13.09.2022 08:13 | SAR | CORRECT: Sareum notes US FDA approval of Bristol-Myers's Sotyktu | Alliance |
12.09.2022 12:27 | SAR | Sareum receives US US Food & Drug Administration approval for Sotyktu | Alliance |
12.09.2022 07:00 | SAR | Sareum notes FDA approval of first TYK2 Inhibitor | Reach |
28.07.2022 07:00 | SAR | CTA application to MHRA and Corporate Update | RNS |
04.07.2022 11:23 | GSK, SAR | IN BRIEF: Sareum notes updated payment terms after GSK buy of SRA737 | Alliance |
04.07.2022 07:00 | SAR | Sareum notes GSK's completed acquisition of Sierra | RNS |
10.06.2022 11:19 | SAR | Midatech Chair Rolf Stahel retires; Stephen Parker named as successor | Alliance |
26.04.2022 07:00 | SAR | Sareum to Present at BioTrinity 2022 Conference | RNS |
13.04.2022 21:59 | DGI9, TYM, GSP | TRADING UPDATES: Sureserve gets new CFO; Sareum notes GSK buys Sierra | Alliance |
13.04.2022 19:46 | BHL, POLB, HARL | TRADING UPDATES: McKay backs Workspace offer; IOG fixes Blythe fault | Alliance |
13.04.2022 16:00 | SAR | Sareum notes acquisition of Sierra Oncology by GSK | RNS |
13.04.2022 11:05 | SAR | Second Price Monitoring Extn | RNS |
13.04.2022 11:00 | SAR | Price Monitoring Extension | RNS |
11.04.2022 20:51 | SAR, BOOM, MRK | TRADING UPDATES: Pod Point wins BMW deal; Lamprell seals contract | Alliance |
11.04.2022 07:00 | SAR | European Patent Granted for Sareum’s SDC-1802 | RNS |
08.04.2022 16:41 | SAR | Second Price Monitoring Extn | RNS |
08.04.2022 16:36 | SAR | Price Monitoring Extension | RNS |
06.04.2022 14:06 | SAR | Second Price Monitoring Extn | RNS |
06.04.2022 14:00 | SAR | Price Monitoring Extension | RNS |
16.03.2022 07:00 | SAR | SDC-1801: Preclinical Toxicology Report Received | RNS |
09.03.2022 11:06 | SAR | Second Price Monitoring Extn | RNS |
09.03.2022 11:00 | SAR | Price Monitoring Extension | RNS |
28.02.2022 15:50 | SAR | Results of EGM | RNS |
21.02.2022 18:13 | PCFT, BVX, SAR | TRADING UPDATES: Bank of Cyprus swings profit; Sareum loss widens | Alliance |
21.02.2022 15:55 | SAR, RFX, ALF | UK shareholder meetings calendar - next 7 days | Alliance |
21.02.2022 07:00 | SAR | Half-year Report | RNS |
14.02.2022 14:06 | SAR | Second Price Monitoring Extn | RNS |
14.02.2022 14:01 | SAR | Price Monitoring Extension | RNS |
04.02.2022 14:37 | SAR | IN BRIEF: Drug maker Sareum plans 50-into-1 share consolidation | Alliance |
04.02.2022 07:00 | SAR | Publication of Circular; Notice of General Meeting | RNS |
28.01.2022 08:11 | SAR | Correction - Issue of Warrants | RNS |
28.01.2022 07:00 | SAR | Issue of Warrants | RNS |
25.01.2022 07:00 | SAR | Sareum to Participate in Edison Open House Event | Reach |
17.12.2021 07:00 | SAR | Subscription to raise £1.63m to progress SDC-1801 | RNS |
16.12.2021 16:21 | SAR | Result of AGM | RNS |
16.12.2021 07:00 | SAR | AGM Statement | RNS |
15.12.2021 07:00 | SAR | Intention to grant notice - EU patent for SDC-1802 | RNS |
07.12.2021 07:00 | SAR | AGM Update | RNS |
23.11.2021 12:57 | SAR | Director/PDMR Shareholding | RNS |
19.11.2021 07:00 | SAR | Notice of AGM | RNS |
03.11.2021 15:00 | SAR | Exercise of Share Options and Director Dealings | RNS |
29.10.2021 07:00 | SAR | Appointment of Joint Corporate Broker | RNS |
25.10.2021 07:00 | SAR | Sareum: Final Results for Year Ended 30 June 2021 | RNS |
21.10.2021 08:32 | SAR | Correction - Notice of Results | RNS |
21.10.2021 07:00 | SAR | Notice of Results and Investor Presentation | RNS |
07.10.2021 10:42 | SAR | US Patent Granted for SDC-1802 TYK2/JAK1 Inhibitor | RNS |
29.09.2021 10:46 | SAR | Reference to SRA737 Timeline at Cantor Conference | RNS |
19.08.2021 07:00 | SAR | Trading Statement | RNS |
09.08.2021 13:26 | SAR | Subscription to raise £1,000,000 | RNS |
06.08.2021 07:19 | SAR | SRA737 update | RNS |
30.07.2021 07:00 | SAR | US Patent Notice of Allowance for SDC-1802 | RNS |
19.07.2021 14:05 | SAR | Second Price Monitoring Extn | RNS |
19.07.2021 14:01 | SAR | Price Monitoring Extension | RNS |
19.07.2021 11:13 | SAR | Subscription to raise £1,000,000 | RNS |
14.07.2021 07:00 | SAR | Exercise of Warrants and Total Voting Rights | RNS |
01.07.2021 07:00 | SAR | Covid-19 Research Project Results | RNS |
24.06.2021 14:05 | SAR | Second Price Monitoring Extn | RNS |
24.06.2021 14:00 | SAR | Price Monitoring Extension | RNS |
21.06.2021 08:00 | SAR | Sareum to Present at BioTrinity 2021 Conference | Reach |
17.06.2021 16:40 | SAR | Second Price Monitoring Extn | RNS |
17.06.2021 16:35 | SAR | Price Monitoring Extension | RNS |